301 related articles for article (PubMed ID: 2856902)
21. Nonselective beta-blockade enhances pressor responsiveness to epinephrine, norepinephrine, and angiotensin II in normal man.
Reeves RA; Boer WH; DeLeve L; Leenen FH
Clin Pharmacol Ther; 1984 Apr; 35(4):461-6. PubMed ID: 6705443
[TBL] [Abstract][Full Text] [Related]
22. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
23. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
24. Regional myocardial tissue blood flow during sequential beta 1- and beta 2-adrenergic blockade in cat hearts with acute ischaemia.
Grong K; Stangeland L; Lekven J
Scand J Clin Lab Invest; 1983 Dec; 43(8):647-55. PubMed ID: 6141636
[TBL] [Abstract][Full Text] [Related]
25. Plasma catecholamine responses to exercise after training with beta-adrenergic blockade.
Wolfel EE; Hiatt WR; Brammell HL; Travis V; Horwitz LD
J Appl Physiol (1985); 1990 Feb; 68(2):586-93. PubMed ID: 1969402
[TBL] [Abstract][Full Text] [Related]
26. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Patterson E; Lucchesi BR
Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
[TBL] [Abstract][Full Text] [Related]
27. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
28. Effects of nadolol beta-blockade on blood pressure in hypertension.
Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
[TBL] [Abstract][Full Text] [Related]
29. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans.
Herman RB; Jesudason PJ; Mustafa AM; Husain R; Choy AM; Lang CC
Br J Clin Pharmacol; 2003 Feb; 55(2):134-8. PubMed ID: 12580984
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of selective beta 1 and nonselective beta-adrenoceptor blockade on epinephrine and atropine response in normal humans.
Gullestad L; Forfang K; Simonsen S
J Cardiovasc Pharmacol; 1992 Dec; 20(6):976-81. PubMed ID: 1282602
[TBL] [Abstract][Full Text] [Related]
32. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
[TBL] [Abstract][Full Text] [Related]
33. Ventilatory effects of atenolol and bevantolol in asthma.
Lammers JW; Folgering HT; van Herwaarden CL
Clin Pharmacol Ther; 1985 Oct; 38(4):428-33. PubMed ID: 4042527
[TBL] [Abstract][Full Text] [Related]
34. Influence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exercise.
Sundberg S; Gordin A
Am J Cardiol; 1986 Jun; 57(15):1394-9. PubMed ID: 2872795
[TBL] [Abstract][Full Text] [Related]
35. Selective and nonselective beta-blockade of the peripheral circulation.
Hiatt WR; Fradl DC; Zerbe GO; Byyny RL; Nies AS
Clin Pharmacol Ther; 1984 Jan; 35(1):12-8. PubMed ID: 6690167
[TBL] [Abstract][Full Text] [Related]
36. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
Almotrefi AA; Dzimiri N
Eur J Pharmacol; 1992 May; 215(2-3):231-6. PubMed ID: 1356792
[TBL] [Abstract][Full Text] [Related]
37. Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives.
Rueckert PA; Slane PR; Hanson P
Med Sci Sports Exerc; 1994 Aug; 26(8):945-50. PubMed ID: 7968427
[TBL] [Abstract][Full Text] [Related]
38. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Beaulieu G; Grimes D; Muirhead C; Oshiro G
Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
[TBL] [Abstract][Full Text] [Related]
39. Beta-blocker duration of action and implications for therapy.
Kostis JB
Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
[TBL] [Abstract][Full Text] [Related]
40. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
